https://www.selleckchem.com/products/AT9283.html
Neisseria meningitidis is a major cause of meningitis and septicaemia. A MenB vaccine (4CMen was licensed by the European Medicines Agency in January 2013. Here we describe the blood transcriptome and proteome following infant immunisations with or without concomitant 4CMenB, to gain insight into the molecular mechanisms underlying post-vaccination reactogenicity and immunogenicity. Infants were randomised to receive control immunisations (PCV13 and DTaP-IPV-Hib) with or without 4CMenB at 2 and 4 months of age. Blood gene expression an
Like
Comment
Share
